Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹708 Cr
up ₹137 Cr vs Jul 2020
- Stocks held
- 25
- unchanged
- Top 10 weight
- 56.9%
- of the portfolio in its ten largest
- Cash & debt
- 4.9%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 5
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In August 2020 it disclosed 25 stocks worth ₹708 Cr, up ₹137 Cr from Jul 2020. Its largest positions were IPCA Laboratories Limited (8.1%), Dr. Reddy's Laboratories Limited (7.9%), Cipla Limited (7.5%); the ten largest together made up 56.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 64.7% of its equity. Cash and debt stood at 4.9%. Compared with Jul 2020 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
76%
Top-10 weight is higher than 76% of peers
Breadth
8%
Holds more stocks than 8% of peers
Cash
71%
Holds more cash than 71% of peers
What these mean: concentration · cash
Holdings in August 2020
Download CSVEvery line the fund disclosed, with the change against Jul 2020. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| IPCA Laboratories Limited | 8.05% | down 1.29 pts | ₹57 Cr | up ₹3.7 Cr | Added |
| Dr. Reddy's Laboratories Limited | 7.85% | down 1.21 pts | ₹55.6 Cr | up ₹3.9 Cr | Added |
| Cipla Limited | 7.49% | up 1.71 pts | ₹53 Cr | up ₹20 Cr | Added |
| Divi's Laboratories Limited | 6.79% | down 0.27 pts | ₹48.1 Cr | up ₹7.8 Cr | Added |
| JB Chemicals & Pharmaceuticals Limited | 5.95% | down 1.23 pts | ₹42.1 Cr | up ₹1.2 Cr | Added |
| Aarti Drugs Limited | 5.29% | up 0.41 pts | ₹37.4 Cr | up ₹9.6 Cr | Added |
| Procter & Gamble Health Limited | 4.96% | up 1.82 pts | ₹35.1 Cr | up ₹17.2 Cr | Added |
| Cash, TREPS & receivables | 4.95% | down 1.07 pts | ₹35 Cr | up ₹68 L | Added |
| Abbott Laboratories | 3.64% | up 0.59 pts | ₹25.8 Cr | up ₹8.4 Cr | Added |
| Intuitive Surgical Inc | 3.44% | up 0.59 pts | ₹24.4 Cr | up ₹8.1 Cr | Added |
| Jubilant Pharmova Limited | 3.40% | down 0.88 pts | ₹24.1 Cr | down ₹36 L | Trimmed |
| Alkem Laboratories Limited | 3.35% | up 1.43 pts | ₹23.7 Cr | up ₹12.7 Cr | Added |
| Torrent Pharmaceuticals Limited | 3.35% | down 0.20 pts | ₹23.7 Cr | up ₹3.5 Cr | Added |
| Apollo Hospitals Enterprise Limited | 3.28% | up 0.52 pts | ₹23.2 Cr | up ₹7.5 Cr | Added |
| Dr. Lal Path Labs Limited | 3.24% | up 0.25 pts | ₹22.9 Cr | up ₹5.9 Cr | Added |
| Syngene International Limited | 3.11% | up 0.42 pts | ₹22 Cr | up ₹6.7 Cr | Added |
| Narayana Hrudayalaya Limited | 3.01% | up 0.20 pts | ₹21.3 Cr | up ₹5.3 Cr | Added |
| Abiomed Inc | 2.99% | up 0.45 pts | ₹21.2 Cr | up ₹6.7 Cr | Added |
| Max Healthcare Institute Limited | 2.92% | up 1.27 pts | ₹20.7 Cr | up ₹11.2 Cr | Added |
| Indoco Remedies Limited | 2.69% | down 0.61 pts | ₹19 Cr | up ₹21 L | Added |
| ICICI Lombard General Insurance Company Limited | 2.55% | down 0.73 pts | ₹18 Cr | down ₹67 L | Trimmed |
| Alembic Pharmaceuticals Limited | 2.46% | down 0.73 pts | ₹17.4 Cr | down ₹79 L | Trimmed |
| Unichem Laboratories Limited | 2.23% | down 0.47 pts | ₹15.8 Cr | up ₹36 L | Added |
| Abbott India Limited | 1.46% | down 0.26 pts | ₹10.3 Cr | up ₹53 L | Added |
| Ajanta Pharma Limited | 1.14% | down 0.41 pts | ₹8.1 Cr | down ₹79 L | Trimmed |
| Advaita Allied Health Services Limited | 0.40% | down 0.31 pts | ₹2.8 Cr | down ₹1.2 Cr | Trimmed |
What changed, Jul 2020 to Aug 2020
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Cipla Limitedup ₹20 Cr (+1.71% pts)
- Procter & Gamble Health Limitedup ₹17.2 Cr (+1.82% pts)
- Alkem Laboratories Limitedup ₹12.7 Cr (+1.43% pts)
- Max Healthcare Institute Limitedup ₹11.2 Cr (+1.27% pts)
- Aarti Drugs Limitedup ₹9.6 Cr (+0.41% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2020, the weight rose most in Healthcare Services (+2.8 pts) and Healthcare Equipment & Supplies (+0.6 pts), and fell most in Pharmaceuticals & Biotechnology (−1.9 pts) and Insurance (−0.8 pts).
- Healthcare Services17.2% → 19.9%+2.8 pts
- Healthcare Equipment & Supplies3.0% → 3.6%+0.6 pts
- Pharmaceuticals & Biotechnology66.7% → 64.7%−1.9 pts
- Insurance3.5% → 2.7%−0.8 pts
- Pharmaceuticals9.6% → 9.0%−0.6 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2019 | Feb 2020 | May 2020 | Jul 2020 | Aug 2020 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.1% | 66.5% | 70.4% | 66.7% | 64.7% |
| Healthcare Services | 17.1% | 21.1% | 15.0% | 17.2% | 19.9% |
| Pharmaceuticals | 11.1% | 11.2% | 10.3% | 9.6% | 9.0% |
| Healthcare Equipment & Supplies | — | — | 2.2% | 3.0% | 3.6% |
| Insurance | 1.7% | 1.2% | 2.2% | 3.5% | 2.7% |
Allocation in Aug 2020change vs Jul 2020
- Pharmaceuticals & Biotechnology (13)64.7%▼ 1.9 pts
- Healthcare Services (7)19.9%▲ 2.8 pts
- Pharmaceuticals (3)9.0%▼ 0.6 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Aug 2020
4.9%
▼ 1.1 pts vs Jul 2020
- Cash alone
- 5.0%
- cash and net receivables
- A year earlier
- 2.3%
- Aug 2019 · now ▲ 2.6 pts
- Last 12 months
- 1.7% – 7.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.